Product Code: GDME1393EPD
GlobalData's Medical Devices sector report, "Inhalable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Inhalable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Inhalable Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inhalable Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Inhalable Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Inhalable Drug Delivery Overview
3 Products under Development
- 3.1 Inhalable Drug Delivery - Pipeline Products by Stage of Development
- 3.2 Inhalable Drug Delivery - Pipeline Products by Segment
- 3.3 Inhalable Drug Delivery - Pipeline Products by Territory
- 3.4 Inhalable Drug Delivery - Pipeline Products by Regulatory Path
- 3.5 Inhalable Drug Delivery - Pipeline Products by Estimated Approval Date
- 3.6 Inhalable Drug Delivery - Ongoing Clinical Trials
4 Inhalable Drug Delivery - Pipeline Products under Development by Companies
- 4.1 Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
- 4.2 Inhalable Drug Delivery - Pipeline Products by Stage of Development
5 Inhalable Drug Delivery Companies and Product Overview
- 5.1 Acerus Pharmaceuticals Corp Company Overview
- 5.2 Acorda Therapeutics Inc Company Overview
- 5.3 Actervis GmbH Company Overview
- 5.4 Aerami Therapeutics Inc Company Overview
- 5.5 Aerophase Inc Company Overview
- 5.6 Alexza Pharmaceuticals Inc Company Overview
- 5.7 Baxter International Inc Company Overview
- 5.8 Bellerophon Therapeutics Inc Company Overview
- 5.9 Breath Therapeutics Holding BV Company Overview
- 5.10 California Northstate University College of Medicine Company Overview
- 5.11 Canigma A.L LTD Company Overview
- 5.12 Cipla Ltd Company Overview
- 5.13 Department of Biomedical Engineering Columbia University Company Overview
- 5.14 Edixomed Ltd Company Overview
- 5.15 Engage Therapeutics Inc Company Overview
- 5.16 iDTx Systems, Inc. Company Overview
- 5.17 Impel Pharmaceuticals Inc Company Overview
- 5.18 Inhalation Sciences Sweden AB Company Overview
- 5.19 Invero Pharma LLC Company Overview
- 5.20 Jupiter Research LLC Company Overview
- 5.21 Kanabo Research Ltd Company Overview
- 5.22 Lupin Pharmaceuticals Inc Company Overview
- 5.23 Mallinckrodt Plc Company Overview
- 5.24 Medical Developments International Ltd Company Overview
- 5.25 Medspray BV Company Overview
- 5.26 Monash University Company Overview
- 5.27 Nemera La Verpilliere Company Overview
- 5.28 Next Safety, Inc. Company Overview
- 5.29 Nobilis Therapeutics Inc Company Overview
- 5.30 OncoSec Medical Inc Company Overview
- 5.31 Pharmosa Biopharm Inc Company Overview
- 5.32 Rhinomed Ltd Company Overview
- 5.33 Risproly Company Overview
- 5.34 Rutgers Cancer Institute of New Jersey Company Overview
- 5.35 Sandoz International GmbH Company Overview
- 5.36 Seng Vital International GmbH Company Overview
- 5.37 Shenzhen Smoore Technology Ltd Company Overview
- 5.38 Sino Biopharmaceutical Ltd Company Overview
- 5.39 Technology Commercialization Partners LLC Company Overview
- 5.40 Tetra Bio-Pharma Inc Company Overview
- 5.41 Teva Pharmaceutical Industries Ltd Company Overview
- 5.42 Texas Tech University Health Sciences Center Company Overview
- 5.43 Third Pole Inc Company Overview
- 5.44 Tiziana Life Sciences PLC Company Overview
- 5.45 Torrent Pharmaceuticals Ltd Company Overview
- 5.46 University Hospital Southampton NHS Foundation Trust Company Overview
- 5.47 University of Texas Health Science Center at Houston Company Overview
- 5.48 Vectura Group Plc Company Overview
- 5.49 Veoli Ltd Company Overview
- 5.50 Vero Biotech LLC Company Overview
- 5.51 Via Therapeutics LLC Company Overview
- 5.52 Virpax Pharmaceuticals Inc Company Overview
- 5.53 VistaGen Therapeutics Inc Company Overview
- 5.54 VitalMIST Company Overview
- 5.55 Wellfully Ltd Company Overview
- 5.56 Windtree Therapeutics Inc Company Overview
6 Inhalable Drug Delivery- Recent Developments
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer